Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 55 min ago
Peer-reviewedPublisher termsDiabetes, Obesity, and Cardiometabolic CARE

SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis

  • Raveendhara R. Bannuru1,2,3,4,5
  • Katherine Fazioli1
  • Nicole M. Bhave6
  • Ian H. de Boer7
  • Amy Earley8
  • Nuha A. ElSayed1,2,4,5,9
  • Kamlesh Khunti10
  • Sankar D. Navaneethan11,12
  • Joshua J. Neumiller13
  • Meredith Noble1
  • Caroline Richardson14
  • Peter Rossing15,16
5 more authors
  • Shylaja Srinivasan17
  • Katherine R. Tuttle18
  • Deborah J. Wexler2,19
  • Sylvia E. Rosas2,20
  • Paola Fioretto21
21 affiliations
  1. 1American Diabetes Association, Arlington, VA
  2. 2Harvard Medical School, Boston, MA
  3. 3Tufts University School of Medicine, Boston, MA
  4. 4Diabetes Education For All (DEFA) Foundation, New York, NY
  5. 5Supercharged Scientific, Wellesley, MA
  6. 6Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Health, Ann Arbor, MI
  7. 7Kidney Research Institute and Department of Medicine, University of Washington, Seattle, WA
  8. 8Kidney Disease: Improving Global Outcomes (KDIGO), Brussels, Belgium
  9. 9Brigham and Women’s Hospital, Boston, MA
  10. 10Diabetes Research Centre, University of Leicester, Leicester, U.K.
  11. 11Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, TX
  12. 12Renal Section, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX
  13. 13College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA
  14. 14Brown University, Providence, RI
  15. 15Steno Diabetes Center Copenhagen, Copenhagen, Denmark
  16. 16University of Copenhagen, Copenhagen, Denmark
  17. 17University of California, San Francisco, San Francisco, CA
  18. 18University of Washington, Spokane, WA
  19. 19Diabetes Center, Massachusetts General Hospital, Boston, MA
  20. 20Joslin Diabetes Center, Boston, MA
  21. 21Department of Medicine, University of Padova, Padova, Italy
Read full textDOICite

Related

  1. RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis
    Raveendhara R. Bannuru, Katherine Fazioli, Ian H. de Boer +14
    Diabetes, Obesity, and Cardiometabolic CAREPeer-reviewedPublisher termsFull textEndocrinology & metabolismPMC
  2. PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials
    P.-M. Morice, I. Ray-Coquard, K.N. Moore +2
    Annals of OncologyPeer-reviewedLicence not statedFull text8 citedOncologyHAL
  3. SodiUm Glucose cotransport 2 and combined 1/2 inhibitors: a systematic Review and network meta-analysis of efficacy and safety in Heart Failure across the range of ejection fraction and with or without diabetes multimorbidity (SUGAR-HF)
    Krishna Tiwari, Muhammad Aaqib Shamim, Vikas Kumar Tiwari +12
    Systematic ReviewsPeer-reviewedCC BY 4.0Cardiovascular medicineCrossref
  4. Oral Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Ischemic Stroke or High‐Risk Transient Ischemic Attack: Systematic Review and Meta‐Analysis
    Mirza Ammar Arshad, Hina Nadeem, Maham Afzal +9
    Brain and behaviorPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCDOAJ
  5. Effects of Renin–Angiotensin Inhibitors, Sodium–Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon‐Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta‐Analysis
    Frances Perry, Silvia J. Leon, Kate Polecina +10
    Diabetes, Obesity & MetabolismPeer-reviewedCC BY-NC 4.0Full textEndocrinology & metabolismPMC

Cite

BibTeXRIS
BibTeX
@article{bannuru2026sglt2,
  title = {{SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis}},
  author = {Raveendhara R. Bannuru and Katherine Fazioli and Nicole M. Bhave and Ian H. de Boer and Amy Earley and Nuha A. ElSayed and Kamlesh Khunti and Sankar D. Navaneethan and Joshua J. Neumiller and Meredith Noble and Caroline Richardson and Peter Rossing and Shylaja Srinivasan and Katherine R. Tuttle and Deborah J. Wexler and Sylvia E. Rosas and Paola Fioretto},
  journal = {Diabetes, Obesity, and Cardiometabolic CARE},
  year = {2026},
  month = jun,
  doi = {10.2337/doci26-0001},
  url = {https://doi.org/10.2337/doci26-0001},
}
RIS
TY  - JOUR
TI  - SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis
AU  - Raveendhara R. Bannuru
AU  - Katherine Fazioli
AU  - Nicole M. Bhave
AU  - Ian H. de Boer
AU  - Amy Earley
AU  - Nuha A. ElSayed
AU  - Kamlesh Khunti
AU  - Sankar D. Navaneethan
AU  - Joshua J. Neumiller
AU  - Meredith Noble
AU  - Caroline Richardson
AU  - Peter Rossing
AU  - Shylaja Srinivasan
AU  - Katherine R. Tuttle
AU  - Deborah J. Wexler
AU  - Sylvia E. Rosas
AU  - Paola Fioretto
PY  - 2026
DA  - 2026/06/23
JO  - Diabetes, Obesity, and Cardiometabolic CARE
DO  - 10.2337/doci26-0001
UR  - https://doi.org/10.2337/doci26-0001
SN  - 3067-3518
SN  - 3067-3534
ER  -